Access the full text.
Sign up today, get DeepDyve free for 14 days.
E. Fride, R. Mechoulam (2003)
New Advances in the Identification and Physiological Roles of the Components of the Endogenous Cannabinoid System
L. Matsuda, S. Lolait, M. Brownstein, A. Young, T. Bonner (1990)
Structure of a cannabinoid receptor and functional expression of the cloned cDNANature, 346
S. Ghozland, H. Matthes, F. Simonin, D. Filliol, B. Kieffer, R. Maldonado (2002)
Motivational Effects of Cannabinoids Are Mediated by μ-Opioid and κ-Opioid ReceptorsThe Journal of Neuroscience, 22
D. Braida, Morena Pozzi, R. Cavallini, M. Sala (2001)
Conditioned place preference induced by the cannabinoid agonist CP 55,940: interaction with the opioid systemNeuroscience, 104
T. Rubino, G. Patrini, Paola Massi, Domenica Fuzio, D. Vigano', Gabriella Giagnoni, D. Parolaro (1998)
Cannabinoid-precipitated withdrawal: a time-course study of the behavioral aspect and its correlation with cannabinoid receptors and G protein expression.The Journal of pharmacology and experimental therapeutics, 285 2
R. Maldonado, L. Stinus, L. Gold, G. Koob (1992)
Role of different brain structures in the expression of the physical morphine withdrawal syndrome.The Journal of pharmacology and experimental therapeutics, 261 2
J. Cheer, Dave Kendall, C. Marsden (2000)
Cannabinoid receptors and reward in the rat: a conditioned place preference studyPsychopharmacology, 151
K. Franklin, G. Paxinos (2001)
The Mouse Brain in Stereotaxic Coordinates
M. Martellotta, G. Cossu, L. Fattore, G. Gessa, Walter Fratta (1998)
Self-administration of the cannabinoid receptor agonist WIN 55,212-2 in drug-naive miceNeuroscience, 85
(1979)
Self-administration of delta9-tetrahydrocannabinol by rats
A. Ameri (1999)
The effects of cannabinoids on the brainProgress in Neurobiology, 58
Z. Justinova, Gianlugi Tanda, G. Redhi (2004)
Self-administration of Delta(9)-tetrahydrocannabinol (THC) bydrug naive squirrel monkeysPsychopharmacology
E. Valjent, R. Maldonado (2000)
A behavioural model to reveal place preference to delta 9-tetrahydrocannabinol in mice.Psychopharmacology, 147 4
M. Herkenham, A. Lynn, Little, J. Mr, L. Melvin, deCosta Br, K. Rice (1990)
Cannabinoid receptor localization in brain.Proceedings of the National Academy of Sciences of the United States of America, 87 5
(2003)
Regulation of extracellular signal-regulated
M. Diana, M. Melis, A. Muntoni, G. Gessa (1998)
Mesolimbic dopaminergic decline after cannabinoid withdrawal.Proceedings of the National Academy of Sciences of the United States of America, 95 17
(2002)
Involvement of CB1 cannabinoid receptors
A. Zimmer, A. Zimmer, A. Hohmann, M. Herkenham, T. Bonner (1999)
Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice.Proceedings of the National Academy of Sciences of the United States of America, 96 10
P. Derkinderen, E. Valjent, M. Toutant, J. Corvol, H. Enslen, C. Ledent, J. Trzăskos, J. Caboche, J. Girault (2003)
Regulation of Extracellular Signal-Regulated Kinase by Cannabinoids in HippocampusThe Journal of Neuroscience, 23
L. Fattore, G. Cossu, Cristina Martellotta, W. Fratta (2001)
Intravenous self-administration of the cannabinoid CB1 receptor agonist WIN 55,212-2 in ratsPsychopharmacology, 156
Miquel Martin, C. Ledent, M. Parmentier, R. Maldonado, O. Valverde (2002)
Involvement of CB1 cannabinoid receptors in emotional behaviourPsychopharmacology, 159
M. Sañudo‐Peña, K. Tsou, E. Delay, Andrea Hohman, M. Force, J. Walker (1997)
Endogenous cannabinoids as an aversive or counter-rewarding system in the ratNeuroscience Letters, 223
C. Breivogel, D. Selley, S. Childers (1998)
Cannabinoid Receptor Agonist Efficacy for Stimulating [35S]GTPγS Binding to Rat Cerebellar Membranes Correlates with Agonist-induced Decreases in GDP Affinity*The Journal of Biological Chemistry, 273
Rachel Wilson, R. Nicoll (2002)
Endocannabinoid Signaling in the BrainScience, 296
C. Breivogel, S. Scates, I. Beletskaya, Olivia Lowery, M. Aceto, B. Martin (2003)
The effects of delta9-tetrahydrocannabinol physical dependence on brain cannabinoid receptors.European journal of pharmacology, 459 2-3
O. Valverde, R. Maldonado, E. Valjent, A. Zimmer, A. Zimmer (2000)
Cannabinoid Withdrawal Syndrome Is Reduced in Pre-Proenkephalin Knock-Out MiceThe Journal of Neuroscience, 20
R. Maldonado, Adolfo Saiardi, O. Valverde, T. Samad, B. Roques, E. Borrelli (1997)
Absence of opiate rewarding effects in mice lacking dopamine D2 receptorsNature, 388
O. Valverde, M. Fournié‐Zaluski, B. Roques, R. Maldonado (2005)
The CCKB antagonist PD-134,308 facilitates rewarding effects of endogenous enkephalins but does not induce place preference in ratsPsychopharmacology, 123
R. Maldonado, F. Fonseca (2002)
Cannabinoid Addiction: Behavioral Models and Neural CorrelatesThe Journal of Neuroscience, 22
A. Castañé, P. Robledo, A. Matifas, B. Kieffer, R. Maldonado (2003)
Cannabinoid withdrawal syndrome is reduced in double mu and delta opioid receptor knockout miceEuropean Journal of Neuroscience, 17
S. Ghozland, H. Matthes, F. Simonin, D. Filliol, B. Kieffer, R. Maldonado (2002)
Motivational effects of cannabinoids are mediated by mu-opioid and kappa-opioid receptors.The Journal of neuroscience : the official journal of the Society for Neuroscience, 22 3
(2003)
Cannabinoid withdrawal syndrome
D. Hutcheson, E. Tzavara, C. Smadja, E. Valjent, B. Roques, J. Hanoune, R. Maldonado (1998)
Behavioural and biochemical evidence for signs of abstinence in mice chronically treated with Δ‐9‐tetrahydrocannabinolBritish Journal of Pharmacology, 125
E. Valjent, Rafael Maldonado (2000)
A behavioural model to reveal place preference to Δ9-tetrahydrocannabinol in micePsychopharmacology, 147
Z. Justinova, G. Tanda, G. Redhi, S. Goldberg (2003)
Self-administration of Δ9-tetrahydrocannabinol (THC) by drug naive squirrel monkeysPsychopharmacology, 169
G. Griffin, Peter Atkinson, V. Showalter, Billy Martin, M. Abood (1998)
Evaluation of cannabinoid receptor agonists and antagonists using the guanosine-5'-O-(3-[35S]thio)-triphosphate binding assay in rat cerebellar membranes.The Journal of pharmacology and experimental therapeutics, 285 2
K. Tsou, S. Patrick, J. Walker (1995)
Physical withdrawal in rats tolerant to delta 9-tetrahydrocannabinol precipitated by a cannabinoid receptor antagonist.European journal of pharmacology, 280 3
D. Piomelli (2003)
The molecular logic of endocannabinoid signallingNature Reviews Neuroscience, 4
Lin Lu, Shaoshu Zeng, Dehong Liu, Xiaobo Ceng (2000)
Inhibition of the amygdala and hippocampal calcium/calmodulin-dependent protein kinase II attenuates the dependence and relapse to morphine differently in ratsNeuroscience Letters, 291
S. Munro, K. Thomas, Muna Abu-Shaar (1993)
Molecular characterization of a peripheral receptor for cannabinoidsNature, 365
R. Takahashi, G. Singer (1979)
Self-administration of Δ 9-tetrahydrocannabinol by ratsPharmacology Biochemistry and Behavior, 11
G. Fan, L. Wang, H. Qiu, L. Ma, G. Pei (1999)
Inhibition of calcium/calmodulin-dependent protein kinase II in rat hippocampus attenuates morphine tolerance and dependence.Molecular pharmacology, 56 1
M. Navarro, M. Carrera, W. Fratta, O. Valverde, G. Cossu, L. Fattore, J. Chowen, R. Gómez, I. Arco, M. Villanúa, R. Maldonado, G. Koob, F. Fonseca (2001)
Functional Interaction between Opioid and Cannabinoid Receptors in Drug Self-AdministrationThe Journal of Neuroscience, 21
C. Ledent, O. Valverde, G. Cossu, F. Petitet, J. Aubert, F. Beslot, G. Böhme, A. Imperato, T. Pedrazzini, B. Roques, G. Vassart, W. Fratta, M. Parmentier (1999)
Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice.Science, 283 5400
H. Matthes, R. Maldonado, F. Simonin, O. Valverde, S. Slowe, I. Kitchen, K. Befort, A. Dierich, M. Meur, P. Dollé, E. Tzavara, J. Hanoune, B. Roques, B. Kieffer (1996)
Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the µ-opioid-receptor geneNature, 383
A. Howlett, F. Barth, T. Bonner, G. Cabral, P. Casellas, W. Devane, C. Felder, M. Herkenham, K. Mackie, B. Martin, R. Mechoulam, R. Pertwee (2002)
International Union of Pharmacology. XXVII. Classification of Cannabinoid ReceptorsPharmacological Reviews, 54
S. Ghozland, F. Aguado, J. Espinosa-Parrilla, E. Soriano, R. Maldonado (2002)
Spontaneous network activity of cerebellar granule neurons: impairment by in vivo chronic cannabinoid administrationEuropean Journal of Neuroscience, 16
E. Tzavara, E. Valjent, Cedric Firmo, Magdalena Mas, F. Beslot, N. Defer, B. Roques, J. Hanoune, R. Maldonado (2000)
Cannabinoid withdrawal is dependent upon PKA activation in the cerebellumEuropean Journal of Neuroscience, 12
F. Fonseca, M. Carrera, M. Navarro, G. Koob, F. Weiss (1997)
Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal.Science, 276 5321
A. Lichtman, S. Sheikh, H. Loh, B. Martin (2001)
Opioid and cannabinoid modulation of precipitated withdrawal in delta(9)-tetrahydrocannabinol and morphine-dependent mice.The Journal of pharmacology and experimental therapeutics, 298 3
(1996)
Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid
(1998)
Evaluation of cannabinoid receptor agonists and antagonists using the guanosine-50-O-(3-[35S]thio)-tripho
(2001)
Functional interaction between opioid and cannabinoid receptors in drug self-administra
R. Maldonado (2002)
Study of cannabinoid dependence in animals.Pharmacology & therapeutics, 95 2
G. Koob (2003)
Neuroadaptive mechanisms of addiction: studies on the extended amygdalaEuropean Neuropsychopharmacology, 13
We have evaluated several responses induced by the cannabinoid agonist WIN 55,212‐2 related to its addictive properties, including rewarding effects and the development of physical dependence in mice. Moreover, we have studied the specific involvement of several brain regions with high density of CB1 cannabinoid receptors, such as striatum, hippocampus, amygdala and cerebellum, in the behavioural expression of SR 141716A‐precipitated WIN 55,212‐2 withdrawal. The systemic administration of the CB1 receptor antagonist SR 141716A (10 mg kg−1, s.c.) precipitated behavioural signs of withdrawal in mice chronically treated with WIN 55,212‐2 (1 and 2 mg kg−1, intraperitoneal (i.p.)), revealing the development of physical dependence. The microinjection of SR 141716A (1.5 and 3 μg) into the cerebellum induced severe manifestations of abstinence in mice dependent on WIN 55,212‐2 (1 mg kg−1, i.p.). Out of 10 signs evaluated, seven were statistically significant: wet dog shakes, body tremor, paw tremor, piloerection, mastication, genital licks and sniffing. When the cannabinoid antagonist was administered into the hippocampus and the amygdala, a moderate but significant withdrawal syndrome was also observed. However, no signs of abstinence were induced when SR 141716A was microinjected into the striatum. WIN 55,212‐2 produced rewarding effects in the place‐conditioning paradigm in mice pre‐exposed to a priming injection of the drug. These results show a reliable behavioural model to reveal rewarding effects and physical dependence induced by the repeated administration of WIN 55,212‐2 in mice. The cerebellum and to a lesser extent the hippocampus and the amygdala participate in the behavioural expression of cannabinoid withdrawal. British Journal of Pharmacology (2004) 142, 1309–1317. doi:10.1038/sj.bjp.0705882
British Journal of Pharmacology – Wiley
Published: Aug 1, 2004
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.